Categories: AppsNews

Reprise Introduces Ability to Inject Custom Datasets into Live Apps and Demos

New Data Studio capabilities extend platform and enable fast, customized demo creation — accelerating sales cycles and saving presales teams demo prep and delivery time

BOSTON, Sept. 12, 2024 /PRNewswire/ — Today, Reprise adds new capabilities to its platform, helping sales and presales teams deliver the right demo at the right time by injecting custom data into their demo environment of choice. Powered by its new Data Studio, Reprise lets organizations populate an empty demo, tailor the story for every audience, and customize elements like charts and graphs — all while saving presales teams time and effort. Sales reps can easily swap datasets to tell the most relevant stories, helping them increase win rates and accelerate deals.

“Without the right data, demos fail,” said Danny Ramos, Senior Product Manager, Verusen. “Changing data in a demo was impossible without hours from engineers. Now we can add data to our live demos on demand with Reprise, making our product story relevant to every prospect. Our sales teams can move faster on opportunities and close more deals.”

Data Studio is unique in that it lets teams inject data into either a self-contained demo environment or a live production environment. Some prefer to add or change datasets in a dedicated demo environment for more stability, customization, and control. Others prefer filling their production application with data. Regardless of the method, Reprise makes it easier to fill demos with the right data, consistently and at scale.

“Data Studio is a powerful complement to the entire Reprise platform, supporting customers no matter how they demo,” said Sarah Idriss, VP of Product Management at Reprise. ” Whether you’re demoing from a self-contained environment like Reprise Replicate™, or a live production application, only Reprise provides the type of flexibility enterprises demand. No matter what story you want to tell, you can do it with Reprise.”

About Reprise
Reprise is the leading comprehensive demo creation platform for enterprise presales, sales, and marketing teams. Reprise allows users to seamlessly build customized sales demos, interactive leave-behinds, complete sandbox environments, and high-performing product tours in a single, powerful platform. With Reprise, enterprise sales and marketing teams shorten sales cycles, lower acquisition costs, increase conversion, and confidently show the value of their products in every interaction.

Launched in 2020, Reprise has been recognized for its market leadership by Gartner, Forrester, and G2 and is backed by ICONIQ Growth, Bain Capital Ventures, Accomplice VC, and Glasswing Ventures. Reprise has served millions of demos to date for customers that include Cloudera, Databricks, Pendo, ServiceNow, and Zendesk.

Contact:
Laura Kim
marketing@reprise.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/reprise-introduces-ability-to-inject-custom-datasets-into-live-apps-and-demos-302245127.html

SOURCE Reprise

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

21 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

21 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

21 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

21 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

21 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

21 hours ago